Study: 99% of Adults Over 40 Show Shoulder Abnormalities on MRI Scans
By
rbanffy
Toasted just enough. A reliable bake, gently seasoned.
Summary
A study examining shoulder MRI scans in adults over 40 found that 99% showed abnormalities, with similar prevalence in both symptomatic and asymptomatic individuals. The research analyzed 1,204 shoulders, revealing that 90% were asymptomatic while 10% were symptomatic. Among asymptomatic shoulders, 96% had rotator cuff abnormalities, and among symptomatic shoulders, 98% had abnormalities. The prevalence of tendinopathy and partial-thickness tears was similar between groups, though full-thickness tears initially appeared more common in symptomatic groups until statistical adjustments were made.
Key quotes
· 3 pulledOf the 1,076 asymptomatic shoulders, 96 percent had RC abnormalities (1,039 of 1,076), and of the 128 symptomatic shoulders, 98 percent had abnormalities (126 of 128).
Prevalence of tendinopathy and partial-thickness tears was similar between the symptomatic and asymptomatic groups.
It initially looked like full-thickness tears were more common in the symptomatic groups, but when researchers adjusted...
You might also wanna read
Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds
Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a
Spinach-derived photosynthetic treatment shows promise for dry eye disease
Scientists at the National University of Singapore have developed an experimental treatment for dry eye disease that uses photosynthetic mac
Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1
Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
